NuSynth raises $4M seed for AI-driven chemical synthesis
NuSynth Technologies, a Bengaluru-based chemical process innovation startup, has raised Rs 36.5 crore (around $4 million) in a seed funding round co-led by Avaana Capital and Shastra VC.
The startup is developing a platform to redesign chemical synthesis processes by evaluating raw materials, reaction pathways and process economics.
NuSynth uses predictive synthesis models and an AI engine that processes experimental data to inform future research cycles.
Its platform focuses on developing alternative synthesis routes with changes to cost, yield, safety, sustainability and scalability.
Newsletter
The corridor, every morning.
Funding rounds and cross-border capital moves, one email, five minutes.
NuSynth’s initial focus is on pharmaceuticals and electronics chemicals, with plans to develop proprietary chemical processes for commercial applications across multiple chemistry-led sectors.
The fresh capital will be used to develop R&D and technology capabilities, build an initial portfolio of proprietary processes, strengthen scale-up capabilities and expand the team.
NuSynth was founded by Poorvank Purohit, former MD and CEO of Solara Active Pharma Sciences, and Dr Ramesha A R, a postdoctoral researcher at the National Institutes of Health (NIH) in Washington.
The founding team also includes Abhishek Deo and Dipak Bajaj, who have worked with companies such as Zetwerk, Mstack, Ola, JPMorgan, BlackBuck and SUN Mobility.
More in Funding
